Singapore’s A*STAR and HistoIndex Join Forces to Speed Fibrosis Drug Development
Singapore's A*STAR has signed a Memorandum of Understanding with AI digital pathology firm HistoIndex to quantitatively evaluate preclinical therapeutic candidates ...
Singapore's A*STAR has signed a Memorandum of Understanding with AI digital pathology firm HistoIndex to quantitatively evaluate preclinical therapeutic candidates ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine